Prohibits a health benefit plan from requiring a higher out-of-pocket cost for an oral anti-cancer medication than for an intravenously administered cancer medication
| Sponsor: |
Scharnhorst, Dwight (098) |
| Proposed Effective Date: |
8/28/2013 |
| LR Number: |
1839H.01I |
| Last Action: |
This Bill Replaced with a Substitute Bill - Check Primary Bill - HB 593 |
| 04/04/2013 - HCS Reported Do Pass (H) |
| Bill String: |
HB 695 |
| Next House Hearing: |
Hearing not scheduled |
| Calendar: |
Bill currently not on a House calendar |